This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a "massive opportunity." It's called targeted radiopharmaceutical ...
CNBC
8 小時前